Quarterly ResultMay 7, 2026, 04:27 PM
Outset Medical Q1 Revenue $27.9M, Net Loss $19.0M; Gross Margin 43.4%
AI Summary
Outset Medical reported its first-quarter 2026 financial results, with net revenue decreasing 6% to $27.9 million. Despite the revenue dip, the company significantly improved its net loss to $19.0 million from $25.8 million in the prior year. Gross margin expanded by over 600 basis points to 43.4%, driven by record product and service gross margins. The company reiterated its full-year 2026 revenue guidance, expressing confidence in its path to profitability.
Key Highlights
- Net revenue totaled $27.9 million, a decrease of 6% compared to $29.8 million in Q1 2025.
- Net loss was $19.0 million, an improvement from $25.8 million in the prior-year period.
- Gross margin expanded by over 600 basis points to 43.4% (43.8% non-GAAP).
- Product gross margin reached a record high of 52.4%, up from 48.3% in Q1 2025.
- Service and other gross margin was a record 25.5%, significantly up from 9.2% in Q1 2025.
- Net cash used during the quarter was $12 million, less than previously forecasted.
- Total cash, including restricted cash, cash equivalents, and short-term investments, was $161 million.
- Reiterated 2026 revenue guidance of $125 million to $130 million, a 5% to 9% increase over 2025.
Price Impact
More from OM